Grant Info

Gabrielle’s Angel Foundation funds cutting-edge research in the fields of leukemia, lymphoma, and related cancers of the blood. 

Scientific projects focus on cancer prevention, detection and treatment that are most likely to be translated into clinical trials within a 3 – 5 year period. The Foundation not only funds conventional scientific research, but also projects that combine integrative (complementary) therapies or botanical agents. These annual Medical Research Awards total $225,000 and are given over a three-year period.

The top research institutions in the nation are solicited by invitation-only and, once the applications are received, undergo rigorous peer review by the Foundation’s Medical Advisory Board. This panel of experts, led by Stephen D. Nimer, M.D., Director of The University of Miami's Sylvester Comprehensive Cancer Center, selects only the nation's most promising junior investigators for funding. Nearly two thirds of our grantees go on to obtain further funding at the federal level thanks to early career support from Gabrielle’s Angel Foundation.

In recent years, the Foundation has expanded its reach to include the funding of select pediatric oncology initiatives, music therapy programs, and international projects. Gabrielle’s Angel Foundation has supported over 150 leading junior investigators totaling more than $27 million and maintains its status as one of the nation’s largest non-governmental sources of grant support for blood cancer research.


In February 2016, Gabrielle's Angel Foundation announced new grants totaling more than $2 million. Follow this link for a list of this year's Medical Research Award recipients. Read more in our press release here and visit our Facebook page for photos and more.

The Foundation also funded eight one-year grants; an art therapy grant to Cohen Children's Medical Center; and provided support to the Emily Whitehead Foundation and the survivorship program at the Sylvester Comprehensive Cancer Center at the University of Miami, FL. 


Our roster of grantees reads like a Who's Who in leukemia & lymphoma research. Read all the latest news on select past awardees here


In 2012, two teams of former grantees received Collaborative Grant Awards totaling $800,000 made possible by a generous gift from the Marc Rich Foundation. Each team received $400,000 over two years. Medical Advisory Board chair Stephen D. Nimer, M.D. remarked, “What is particularly exciting about these new collaborative grants is that they not only prove the value of the initial investment, they bring scientists and institutions together to significantly accelerate and broaden the impact of their work.”

Ari Melnick, M.D. of Weill Cornell Medical College, Ross Levine, M.D. of Memorial Sloan Kettering Cancer Center and Chuan He, Ph.D. from The University of Chicago were awarded a grant for their project entitled “Decoding the hydroxymethylome of IDH and TET mutant acute leukemias.” Anthony Letai, M.D. of Dana-Farber Cancer Institute worked with Memorial Sloan Kettering’s Scott Armstrong, M.D. on a project were they propose “a completely novel approach to identifying the chemotherapy resistant subsets in [acute myelogenous] leukemia patient samples, identifying the mechanisms making them resistant to chemotherapy, and targeting those mechanisms.”

The Foundation hopes to offer another such collaborative grant in the future.


Our invitation-only grant process is sent in April/May of each year. Therefore, Gabrielle's Angel Foundation does not publish application materials online. For questions about eligibility or for more information, please contact Christa Justus in the Foundation office. Once nominated to apply, candidates may download and reference these Frequently Asked Questions while working on their submissions.